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Background
Provisional evidence-based classification criteria for
Familial Mediterranean Fever (FMF), Cryopyrin Asso-
ciated Periodic Syndrome (CAPS), Tumor Necrosis factor
Receptor Associated Periodic Syndrome (TRAPS) and
Mevalonate Kinase Deficiency (MKD) have been recently
developed based on data coming from the Eurofever reg-
istry. However, no consensus on how to combine clinical
criteria with results of molecular analysis has been
reached so far.
Objectives
To understand how physicians involved in the clinical
care of patients with Autoinflammatory diseases (AIDs)
classify patients with inherited periodic fever in daily
practice.
Methods
By using the Delphi and Nominal Group Technique, we
started a process made of three consecutive e-mail sur-
veys. In the first survey, clinicians/biologists and other
health professionals working in the field of autoinflam-
mation were asked to identify the variables that they
consider as important, in their clinical practice, for the
diagnosis of patients with inherited periodic fever. This
survey was open not to influence the experts.
Results
We sent the first survey to 124 experts. The overall rate
of response was 107 (86%): 101 experts responded to be
interested in the survey and 88 completed and con-
firmed it for at least one disease; 6 experts responded
not to be interested. No clinical variable was chosen by
all the experts for any disease the five most cited clinical
variables for FMF were recurrent fever (80% of experts),
abdominal pain (67%), arthritis (53%), thoracic pain
(47%) and arthralgia (36%). The five most cited clinical
variables for CAPS were fever (75%), urticarial rash
(71%), hearing loss (49%), ocular involvement (40%) and
arthralgia (35%). The five most cited clinical variables
for TRAPS were long lasting fever (92%), rash (84%),
periorbital edema (59%), myalgia/myositis (57%), and
abdominal pain (55%) while the five most cited clinical
variables for MKD were abdominal pain (61%), fever
(59%), skin rash (41%), diarrhea (43%) and arthralgia
(39%). A confirmatory genetic test resulted a relevant
element for the diagnosis of FMF, TRAPS, CAPS and
MKD while the response to treatment for FMF and
CAPS.
Conclusions
The preliminary results of the first Eurofever Delphi
Survey show a high rate of response by Expert, underly-
ing the interest of the scientific community in this topic.
A wide heterogeneity in their response was observed. At
the end of the Delphi process, we will obtain different
set of clinical criteria whose performance will be tested
in comparison to already existing criteria in a cohort of
patients affected by AIDs. The final step will be a Con-
sensus among experts (geneticists and clinicians) in
order to define the best combination of clinical and
genetic data for the definitive classification of patients
with inherited periodic fevers.
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